Principal Investigator: Dr. Ellen Caniglia, ScD
- To assess adoption (intention, initial decision, or action to try to employ an innovation or evidence-based practice), penetration (integration of a practice within a service setting), and fidelity (degree to which an intervention was implemented as it was prescribed) of an intervention to provide MMS at antenatal clinics throughout Botswana for a 6-month period. These implementation outcomes will be measured by calculating the proportion of women receiving MMS at the intervention clinics during the intervention period. These outcomes will be measured via linkage with the Tsepamo birth outcomes surveillance study.
- To assess feasibility of an intervention to provide MMS at antenatal clinics throughout Botswana for a 6-month period. This implementation outcome will be measured via pre- and post-intervention surveys with nurses, midwives, and pharmacists at the intervention clinics.
- To evaluate clinical outcomes (adverse birth outcomes, weight gain in pregnancy, and anaemia) following a 6-month intervention to provide MMS at antenatal clinics throughout Botswana. Clinical outcomes will be measured via linkage with the Tsepamo birth outcomes surveillance study
Study Design: This is a clinic-level pilot intervention study in which MMS (the standard multivitamin) will be provided at up to 15 antenatal clinics. Clinics will receive quantities of MMS sufficient to provide all pregnant women with the supplements for the duration of the intervention.
Study population and size: The study will include pregnant women at up to 15 antenatal clinics throughout Botswana. Sample Size is up to 15 antenatal clinics throughout Botswana with the goal of collecting outcome data for 1200 pregnant women.
Study duration: 6 Months
Study Results: Study is on-going and no data analyses have been done yet